Having found decreased numbers of analyzed stem and progenitor cells in immunocompromised patients, we next aimed to investigate effects of G-CSF treatment on hematopoietic stem cell mobilization in ALL patients. This evidence concerns the gene CSF3 and acute lymphoblastic leukemia.